Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:38 AM
Ignite Modification Date:
2025-12-25 @ 2:38 AM
NCT ID:
NCT05299034
Eligibility Criteria:
* SUBSTUDY 1. OPTIMIZATION OF IMAGING SELECTION METHODS FOR SELECTING STROKE PATIENTS FOR REPERFUSION TREATMENT IN THE EXTENDED WINDOW.
\- Inclusion criteria: Consecutive patients registered in the CICAT registry between the years 2019 and 2021 with a stroke who meet the following criteria
1. Age older than 18 years,
2. Diagnosis of acute cerebral infarction,
3. More than six hours of evolution or uncertain chronology of symptoms,
4. Absence of disability prior to stroke (modified Rankin score 0-2),
5. NIHSS score\>5,
6. Neuroimaging study including at least one non-contrast cranial CT scan within 60 minutes of arrival at the hospital center.
* SUBSTUDY 2. OPTIMIZATION OF CIRCUITS AND TRANSFER MODEL IN PATIENTS WITH STROKE IN THE EXTENDED WINDOW OF TREATMENT.
* Inclusion criteria: Selection of consecutive, prospective patients to be included in the CICAT registry between January 2023 and March 2024 with stroke meeting the following criteria:
1. Age over 18 years,
2. Suspicion of acute cerebral infarction,
3. More than six hours of evolution or uncertain chronology of symptoms,
4. absence of pre-stroke disability (modified Rankin score 0-2),
5. NIHSS score greater than 5.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
100 Years
Study:
NCT05299034
Study Brief:
Protocol Section:
NCT05299034